Seeing Is Believing

Currently out of the existing stock ratings of Yatin Suneja, 173 are a BUY (85.22%), 30 are a HOLD (14.78%).
Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 48.59% that have a potential upside of 51.46% achieved within 284 days.
Yatin Suneja’s has documented 443 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PRAX, Praxis Precision Medicines at 16-Oct-2025.
Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$33
$10.98 (49.86%)
$34
29 days ago
(28-Sep-2025)
8/13 (61.54%)
$11.68 (54.78%)
113
Buy
$28
$5.98 (27.16%)
$30
1 months 4 days ago
(23-Sep-2025)
0/10 (0%)
$6.74 (31.70%)
Buy
$39
$16.98 (77.11%)
$35
1 months 17 days ago
(10-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Buy
$39
$16.98 (77.11%)
$32
1 months 19 days ago
(08-Sep-2025)
1/5 (20%)
$14.16 (57.00%)
349
Hold
$24
$1.98 (8.99%)
$23
2 months 21 days ago
(06-Aug-2025)
10/13 (76.92%)
$-0.4 (-1.64%)
157
Which stock is Yatin Suneja is most bullish on?
Which stock is Yatin Suneja is most reserved on?
What Year was the first public recommendation made by Yatin Suneja?